Can Fite Biopharma Ltd ADR (CANF) has had the highest return between December 23, 2025 and January 6, 2026 by a US stock, returning 1,616%.
| ASSET | DATE | % RETURN |
|---|---|---|
Can Fite Biopharma Ltd ADR (CANF) | 12/23/2025 - 1/6/2026 | 1,616% |
BitVentures (BVC) | 12/23/2025 - 1/6/2026 | 1,278.5% |
WideOpenWest (WOW) | 12/23/2025 - 1/6/2026 | 462.38% |
Sidus Space (SIDU) | 12/23/2025 - 1/6/2026 | 186.96% |
Bristol-Myers Squibb Company Ce (CELG.RI) | 12/23/2025 - 1/6/2026 | 150.57% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | 12/23/2025 - 1/6/2026 | 131.51% |
Brand Engagement Network (BNAI) | 12/23/2025 - 1/6/2026 | 130.57% |
TROOPS (TROO) | 12/23/2025 - 1/6/2026 | 115.05% |
Society Pass (SOPA) | 12/23/2025 - 1/6/2026 | 107.56% |
Republic Power Group Limited Class A Ordinary Shares (RPGL) | 12/23/2025 - 1/6/2026 | 106.82% |
Lavoro Limited Class A Ordinary Shares (LVRO) | 12/23/2025 - 1/6/2026 | 96.11% |
Intelligent Bio Solutions (INBS) | 12/23/2025 - 1/6/2026 | 92.98% |
Cohen (COHN) | 12/23/2025 - 1/6/2026 | 86.89% |
Kaixin Auto (KXIN) | 12/23/2025 - 1/6/2026 | 86.49% |
JE Cleantech (JCSE) | 12/23/2025 - 1/6/2026 | 79.28% |
Sellas Life Sciences (SLS) | 12/23/2025 - 1/6/2026 | 78.57% |
TMD Energy (TMDE) | 12/23/2025 - 1/6/2026 | 76.67% |
Lipocine (LPCN) | 12/23/2025 - 1/6/2026 | 72.58% |
Polyrizon Ltd Ordinary Shares (PLRZ) | 12/23/2025 - 1/6/2026 | 71.64% |
Entero Therapeutics (GRDX) | 12/23/2025 - 1/6/2026 | 70.77% |
Entero Therapeutics (ENTO) | 12/23/2025 - 1/6/2026 | 70.77% |
EUDA Health (EUDA) | 12/23/2025 - 1/6/2026 | 64.75% |
Passage Bio (PASG) | 12/23/2025 - 1/6/2026 | 64.39% |
Omeros (OMER) | 12/23/2025 - 1/6/2026 | 63.31% |
Ekso Bionics (EKSO) | 12/23/2025 - 1/6/2026 | 62.86% |
